These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26954680)

  • 21. Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update.
    Hou G; Xu B; Bi Y; Wu C; Ru B; Sun B; Bai X
    Bosn J Basic Med Sci; 2018 Nov; 18(4):297-304. PubMed ID: 30179586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase.
    Brewitz L; Tumber A; Zhang X; Schofield CJ
    Bioorg Med Chem; 2020 Oct; 28(20):115675. PubMed ID: 33069066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
    Hu MH; Huang TT; Chao TI; Chen LJ; Chen YL; Tsai MH; Liu CY; Kao JH; Chen KF
    Liver Int; 2018 Dec; 38(12):2248-2259. PubMed ID: 29797403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The distribution and expression pro-files of Aspartyl/Asparaginyl beta-hydroxylase (ASPH) in some tumorous cell lines and tissues].
    Song K; Xue XP; Wang W; Huyan T; Wang H; Yang H; Xie Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):141-4. PubMed ID: 20230674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
    Koprowski S; Sokolowski K; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
    J Surg Res; 2015 Oct; 198(2):434-40. PubMed ID: 25890434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors.
    He JC; Yao W; Wang JM; Schemmer P; Yang Y; Liu Y; Qian YW; Qi WP; Zhang J; Shen Q; Yang T
    Oncotarget; 2016 Nov; 7(46):75441-75456. PubMed ID: 27705912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Human Aspartyl (Asparaginyl) β-hydroxylase in NSCLC: Its Diagnostic Value by Means of Exosomes of Bronchoalveolar Lavage.
    Zhu H; Liu H; Wen J; Yuan T; Ren G; Jiang Y; Yuan Y; Mei J; Yu Y; Li G
    Appl Immunohistochem Mol Morphol; 2021 Nov-Dec 01; 29(10):720-727. PubMed ID: 34433181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of ciliary zonule protein hydroxylation and lens stability as a predicted consequence of biallelic ASPH variation.
    Siggs OM; Souzeau E; Craig JE
    Ophthalmic Genet; 2019 Feb; 40(1):12-16. PubMed ID: 30600741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in ASPH cause facial dysmorphism, lens dislocation, anterior-segment abnormalities, and spontaneous filtering blebs, or Traboulsi syndrome.
    Patel N; Khan AO; Mansour A; Mohamed JY; Al-Assiri A; Haddad R; Jia X; Xiong Y; Mégarbané A; Traboulsi EI; Alkuraya FS
    Am J Hum Genet; 2014 May; 94(5):755-9. PubMed ID: 24768550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of Novel Pyridine-Carboxylates as Small-Molecule Inhibitors of Human Aspartate/Asparagine-β-Hydroxylase.
    Brewitz L; Tumber A; Thalhammer A; Salah E; Christensen KE; Schofield CJ
    ChemMedChem; 2020 Jul; 15(13):1139-1149. PubMed ID: 32330361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.
    Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR
    Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspartate/asparagine-β-hydroxylase crystal structures reveal an unexpected epidermal growth factor-like domain substrate disulfide pattern.
    Pfeffer I; Brewitz L; Krojer T; Jensen SA; Kochan GT; Kershaw NJ; Hewitson KS; McNeill LA; Kramer H; Münzel M; Hopkinson RJ; Oppermann U; Handford PA; McDonough MA; Schofield CJ
    Nat Commun; 2019 Oct; 10(1):4910. PubMed ID: 31659163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the Relationship Between the Expression of Aspartate β-Hydroxylase and the Pathological Characteristics of Breast Cancer.
    Zhang Y; Gao Y; Li Y; Zhang X; Xie H
    Med Sci Monit; 2020 Dec; 26():e926752. PubMed ID: 33380715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition.
    Yin Y; Zhang M; Dorfman RG; Li Y; Zhao Z; Pan Y; Zhou Q; Huang S; Zhao S; Yao Y; Zou X
    Cell Death Dis; 2017 Jun; 8(6):e2856. PubMed ID: 28569784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
    Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y
    Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer.
    Benelli R; Costa D; Mastracci L; Grillo F; Olsen MJ; Barboro P; Poggi A; Ferrari N
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32295249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation Modulates Aspartyl-(Asparaginyl)-β Hydroxylase Protein Expression, Catalytic Activity and Migration in Human Immature Neuronal Cerebellar Cells.
    Tong M; Gao JS; Borgas D; de la Monte SM
    Cell Biol (Henderson, NV); 2013 Sep; 6(2):. PubMed ID: 29607347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer activity using positron emission tomography-computed tomography and pharmacokinetics of β-eudesmol in human cholangiocarcinoma xenografted nude mouse model.
    Plengsuriyakarn T; Karbwang J; Na-Bangchang K
    Clin Exp Pharmacol Physiol; 2015 Mar; 42(3):293-304. PubMed ID: 25545782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells.
    Ke F; Wang Z; Song X; Ma Q; Hu Y; Jiang L; Zhang Y; Liu Y; Zhang Y; Gong W
    Drug Des Devel Ther; 2017; 11():1753-1766. PubMed ID: 28670110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
    Seubwai W; Wongkham C; Puapairoj A; Okada S; Wongkham S
    Cancer; 2010 Dec; 116(23):5535-43. PubMed ID: 20681031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.